Bechelli L M, Martínez Domínguez V
Bull World Health Organ. 1966;34(6):811-26.
There is at present a lack of accurate data on the prevalence of leprosy in the different countries of the world, primarily because case-finding has not reached the desired level in many of them. The authors have attempted to provide more realistic figures, using information obtained from several sources and various criteria for calculating estimated prevalence rates.In all there are 2 831 775 registered patients and 10 786 000 estimated cases; the latter figure may well be an underestimate. The number of treated patients is about 1 928 000, some 68% of the registered cases and 18% of the estimated. About 2097 million people live in areas with prevalence rates of 0.5 per 1000 or higher; in these areas nearly one million new cases of leprosy can be expected within the next five years.The estimated number of disabled patients is 3 872 000, of whom 1 961 000 are in disability grades 2-5 (excluding anaesthesia to pain).The data represent an attempt, made with many reservations, to give an indication of the magnitude of the leprosy problem throughout the world.
目前,世界各国麻风病流行率缺乏准确数据,主要原因是许多国家的病例发现工作尚未达到理想水平。作者试图利用从多个来源获得的信息以及计算估计流行率的各种标准,提供更现实的数据。总共有2831775名登记患者和10786000例估计病例;后一个数字很可能被低估了。接受治疗的患者约有1928000人,约占登记病例的68%,估计病例的18%。约20.97亿人生活在麻风病流行率为每千分之0.5或更高的地区;在这些地区,预计未来五年内将出现近100万例新的麻风病病例。估计残疾患者人数为3872000人,其中1961000人属于2 - 5级残疾(不包括对疼痛的麻木)。这些数据是在诸多保留意见的情况下做出的尝试,旨在表明全球麻风病问题的严重程度。